Delivery Order SPE2DB20D9331-SPE2DB22FL1E3

Award Date 7/7/22
Potential Completion Date 7/28/22
Potential Value $86K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $86,440.56 firm fixed-price delivery order is for the supply of ONCASPAR 3,750 UNIT/5 ML VIAL 5ML, a pharmaceutical product, to support the medical supply needs of Department of Defense (DoD) healthcare facilities. The award is part of a larger indefinite delivery contract (IDC) valued at up to...
This federal contract award is for the delivery of 3,750 units of the pharmaceutical drug ONCASPAR 5 ML Vial to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $99,062.80 firm fixed-price contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has an ultimate completion date of March 14, 2023 and is not associated with any set-aside designation. DMS Pharmaceutical Group holds a...
This federal contract award, valued at $41,465.36, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,555,808,561 units of the pharmaceutical product ONCASPAR, a 3,750 unit/5 mL vial. The contract is a firm fixed-price delivery order with a completion date of January 20, 2022, and is not associated with any set-aside designations. DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4,562,515,244 units of the prescription drug ONCASPAR in 5 mL vials, with a ceiling value of $99,257.40 and a period of performance through October 12, 2023. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,531.40 firm fixed-price delivery order is for the supply of 4,565,482,195 units of the medication ONCASPAR 3,750 UNIT/5 ML VIAL 5ML. The contract is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $49,531.40, is a firm fixed-price delivery order for 4,560,593,542 units of the prescription drug ONCASPAR (3,750 units/5 ml vial, 5 ml). The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger single-award Indefinite Delivery...
This federal contract award, valued at $82,930.72, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,555,565,043 units of the oncology drug ONCASPAR in 5 ml vials. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $124,396.08 firm fixed-price delivery order is for the supply of 4,554,408,511 units of the oncology drug ONCASPAR (3,750 unit/5 mL vial, 5 mL) to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $41,494.84 firm fixed-price delivery order is for the supply of 4,556,227,681 units of the prescription drug ONCASPAR (3,750 units/5 mL vial) to support the medical needs of the Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery...
This federal contract award, valued at $43,220.28, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for 4,556,804,083 units of the prescription drug ONCASPAR, a 3,750 unit/5 ml vial, with an ultimate completion date of April 21, 2022. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB22FL1E3
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a firm fixed-price delivery order (SPE2DB22FL1E3) with a ceiling value of $86,440.56 and a completion date of July 28, 2022.

The contract is for the supply of 4,557,808 units of the drug ONCASPAR, a 3,750 unit/5 ml vial, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items through December 31, 2025. This IDC, along with the company's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) sites, solidifies DMS Pharmaceutical Group's position as a crucial supplier in the federal pharmaceutical supply chain.

Generated 1/9/25, 9:14 AM